Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials

  1. Wu, Y.-L.
  2. Sequist, L.V.
  3. Tan, E.-H.
  4. Geater, S.L.
  5. Orlov, S.
  6. Zhang, L.
  7. Lee, K.H.
  8. Tsai, C.-M.
  9. Kato, T.
  10. Barrios, C.H.
  11. Schuler, M.
  12. Hirsh, V.
  13. Yamamoto, N.
  14. O'Byrne, K.
  15. Boyer, M.
  16. Mok, T.
  17. Peil, B.
  18. Märten, A.
  19. Chih-Hsin Yang, J.
  20. Paz-Ares, L.
  21. Park, K.
Aldizkaria:
Clinical Lung Cancer

ISSN: 1938-0690,  1525-7304

Argitalpen urtea: 2018

Alea: 19

Zenbakia: 4

Orrialdeak: e465-e479

Mota: Artikulua

DOI: 10.1016/J.CLLC.2018.03.009 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus